Stay updated on PK and QTc Interaction in Sitravatinib Clinical Trial
Sign up to get notified when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.

Latest updates to the PK and QTc Interaction in Sitravatinib Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUI changes include showing the glossary and minor labeling tweaks (e.g., capitalization of 'Met QC Criteria' and 'No FEAR Act Data'). The revision was updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page now shows an updated revision line: Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be a minor internal version update with no changes to study details or user-facing content.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Location sections for Indiana, Texas, Virginia, and Washington and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the prior Indiana, Texas, Virginia, and Washington location listings.SummaryDifference0.5%

- Check69 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; this appears to be a minor backend update with no changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedFooter shows Revision: v3.3.1 and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check83 days agoChange DetectedThe government funding notice about data currency and NIH operations was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to PK and QTc Interaction in Sitravatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.